PACB News and Press, Pacific Biosciences of California Inc. From 04/21/22

MENLO PARK, Calif., April 21, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the release of a transformative capability to detect DNA methylation using the Sequel IIe and Sequel II Systems . ...

MENLO PARK, Calif., April 20, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2022 financial results on Wednesday, May 4, 2022, at 5:00 pm Eastern Time. The call will be webcast live and may be...

Volatility remains the dominant factor across the equities market, with interest rates rising and growth stocks well underwater so far in 2022. Ground zero for this correction is among “long duration assets”, which includes growth stocks with big hypothetical cash flows down the...

Gainers: Eargo  (EAR) +13%. Intel Corporation (INTC) +6%. eHealth (EHTH) +4%. Trevi Therapeutics (TRVI) +3%. Pacific Biosciences of California (PACB) +3%. Losers: Protagonist Therapeutics (PTGX) -34%. Cambium Networks Corporation (CMBM) -12%. Vir Biotechnology (VIR) -...

At the end of March, the entire human genome was finally fully sequenced -- all 3.1 billion bonded pairs of chemical bases. Until recently, about 8% of the blueprint was missing from the effort celebrated as a full sequence in 2003. The completion could open the door to new medical breakthr...

PacBio shares have been hit hard as investors have abandoned riskier high-multiple life sciences stocks, and weaker guidance for FY'22 certainly didn't help. Illumina's announcement that it will enter long-read sequencing with its Infinity workflow offering is a threat, but I don't se...

PacBio (NASDAQ:PACB) announced an agreement with Corteva Agriscience (CTVA) to develop custom, end-to-end workflows for plant, pest and microbial sequencing. "We are proud to provide a sequencing platform to Corteva Agriscience for use in its development of products that help f...

MENLO PARK, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, announced today a new collaboration with global agriculture company, Corteva Agriscience , to develop custom, end-to-end workflows ...

MENLO PARK, Calif., March 31, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing solutions, announced today PacBio’s essential contribution to the completion of the first truly complete human reference genome. The Telomere...

Baker Brothers’ 13F portfolio value decreased from $22.77B to $20.55B this quarter. Incyte and Legend Biotech stakes were increased this quarter. The top three positions are Seagen, BeiGene, and Incyte Corporation and they add up to almost ~63% of the portfolio. For f...